Monday, January 16, 2023 Daily Archives

Hospira experience will aid Abzena success, says new CEO

by

The experience of leading the operational turnaround at Hospira provides a robust framework for advancing Abzena’s success, says newly appointed CEO Matthew Stober. Contract development manufacturing organization (CDMO) Abzena, which focuses on antibody drug conjugates (ADCs) and biologic molecules, announced this month that Stober would replace Jonathon Goldman as CEO. Most recently, Stober held position of CEO at CastleVax and Istari Oncology. However, while all of his past job roles are undoubtedly influential, his experience of leading the turnaround of…

January 16, 2023

Argonaut to expand fill/finish capabilities in California

by

CMO Argonaut Manufacturing Services will use capital investment led by Telegraph Hill Partners to expand its manufacturing capabilities in Carlsbad, California. Contract manufacturing organization (CMO) Argonaut serves the life sciences, biopharma, and molecular diagnostics space. While specific financial details have not been disclosed, the firm said the investment will be focused on expanding its Carlsbad manufacturing facilities by installing a fill/finish line. According to Argonaut, the addition of a fill/finish line will expand the CMO’s footprint on the west coast…

January 16, 2023

Amgen prepped to take first slice of AbbVie’s US Humira pie

by

Amgen is eyeing up a share of the $17+ billion US adalimumab market with the prospective launch of the first Humira biosimilar, Amjevita, later this month. In its trend report ‘Drugs to watch 2023,’ Clarivate highlights the impending loss of exclusivity of AbbVie’s bestselling drug Humira (adalimumab). The monoclonal antibody has clocked in sales of more than $200 billion for AbbVie (and previously Abbott) since its launch in 2003, with 2021 sales alone pulling in $20.1 billion in sales, $17.3 billion…

January 16, 2023

2023 is the year for plug-in manufacturing, says BioNTech

by

BioNTech will make the first mRNA vaccines in Africa this year using its plug-in manufacturing tech, the firm told JP Morgan Conference delegates. Last week, CEO of BioNTech Ugur Sahin described to JPM delegates how the learnings of the pandemic highlighted that “poor countries didn’t get vaccines doses.” However, Sahin offered up a solution to this, saying “the only way to change that is to implement manufacturing technology.” In particular, he drew upon the company’s activity in Rwanda, Africa but…

January 16, 2023